Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Other Non Operating Income (2018 - 2025)

Exagen (XGN) has disclosed Other Non Operating Income for 7 consecutive years, with -$295000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Non Operating Income changed N/A year-over-year to -$295000.0, compared with a TTM value of -$295000.0 through Dec 2025, down 153.64%, and an annual FY2025 reading of -$295000.0, changed N/A over the prior year.
  • Other Non Operating Income was -$295000.0 for Q2 2025 at Exagen, down from $211000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $339000.0 in Q3 2022 and bottomed at -$295000.0 in Q2 2025.
  • Average Other Non Operating Income over 4 years is $31222.2, with a median of $5000.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income crashed 100.73% in 2021, then soared 11200.0% in 2022.
  • Year by year, Other Non Operating Income stood at $15000.0 in 2021, then soared by 2160.0% to $339000.0 in 2022, then tumbled by 37.76% to $211000.0 in 2023, then crashed by 239.81% to -$295000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for XGN at -$295000.0 in Q2 2025, $211000.0 in Q3 2023, and $339000.0 in Q3 2022.